DSpace Repository

The cytoprotective role of a low-molecular-weight heparin fragment studied in an experimental model of glomerulotoxicity

Show simple item record

dc.contributor.author Deepa, P.R.
dc.date.accessioned 2021-09-19T16:02:58Z
dc.date.available 2021-09-19T16:02:58Z
dc.date.issued 2003
dc.identifier.uri https://www.sciencedirect.com/science/article/pii/S0014299903023586?via%3Dihub#aep-keywords-id8
dc.identifier.uri http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/2130
dc.description.abstract Abnormal glomerular glycosaminoglycan metabolism is involved in the onset of the morphological and functional aberrations of glomerulopathies. In the present study, a heparin derivative, low-molecular-weight heparin, was tested for its ability to afford renoprotection in an established model of experimental glomerulopathy. Two groups of male albino rats of the Wistar strain (140±10 g) received a single intravenous injection of adriamycin (7.5 mg/kg) to induce glomerulopathy, and one of them received low-molecular-weight heparin (Certoparin Sodium, Troparin®; 300 μg/day/rat s.c.) treatment, commencing on day 8, for a week. Urinary protein/creatinine ratio, serum albumin, urea, uric acid and creatinine clearance were evaluated. Renal cell injury was assessed in terms of renal tissue lactate dehydrogenase, aminotransferases (aspartate and alanine transaminases) and alkaline phosphatase activities, as well as renal antioxidant status (superoxide dismutase, catalase and glutathione peroxidase, reduced glutathione, vitamins E and C). The kidney tissue was subjected to histopathologic examination. Low-molecular-weight heparin significantly reduced proteinuria and improved creatinine clearance and serum albumin levels in the rats with glomerulopathy. The significant rise in serum uric acid in the rats with glomerulopathy was reversed by low-molecular-weight heparin. Altered tissue enzyme activities in response to injury, oxidative stress challenged renal antioxidant system and abnormal renal histology were observed in the untreated nephrotic rats, while low-molecular-weight heparin treatment protected the nephrotic rats against these changes. Thus, in this study, low-molecular-weight heparin was evaluated for its role in combating glomerular injury, on the basis of some salient biochemical parameters, oxidative injury indices and histologic picture. The ability of low-molecular-weight heparin to restore glomerular anatamo-functional features in this nephrotoxic condition illuminates its multi-faceted renoprotective role. en_US
dc.language.iso en en_US
dc.publisher Elsiever en_US
dc.subject Biology en_US
dc.subject Low-molecular-weight heparin en_US
dc.subject Adriamycin Glomerulopathy en_US
dc.subject Glycosaminoglycan en_US
dc.title The cytoprotective role of a low-molecular-weight heparin fragment studied in an experimental model of glomerulotoxicity en_US
dc.type Article en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account